Bracanat 100mg Tablets (Olaparib) | Uses & Safety Information

Bracanat 100mg Tablets contain olaparib, an oral anticancer medicine belonging to a class of drugs known as PARP (poly ADP-ribose polymerase) inhibitors. Olaparib works by blocking specific enzymes involved in DNA repair, making it harder for certain cancer cells with particular DNA-repair deficiencies to survive.

Bracanat is available in tablet form and is used for selected cancer treatment indications according to the patient's diagnosis, biomarker status and treatment history. Its suitability depends on the specific indication and the prescribing oncologist's assessment.

Product name: Bracanat 100mg Tablets

Active ingredient: Olaparib 100mg

Dosage form: Film-coated oral tablets

Therapeutic category: PARP inhibitor; anticancer medicine

Manufacturer information: Verify against the current product packaging and approved product documentation.

Uses and Potential Benefits of Bracanat 100mg

Olaparib may be prescribed for certain patients with ovarian, breast, prostate or pancreatic cancer, depending on the cancer type, genetic biomarkers, previous treatments and applicable treatment guidelines.

Potential benefits include:

Targeted treatment approach: Olaparib targets DNA-repair pathways that are important for the survival of certain cancer cells.

Maintenance therapy: For eligible patients, it may help delay disease progression after an initial response to other cancer treatments.

Biomarker-guided treatment: Certain indications depend on BRCA mutations or other specific molecular characteristics.

Oral administration: Tablets allow treatment outside an infusion setting, although regular medical monitoring remains essential.

These potential benefits vary by cancer type and individual circumstances. Bracanat is not suitable for every cancer patient and should only be used for an indication supported by the applicable prescribing information.

Bracanat 100mg Side Effects

Like other anticancer medicines, Bracanat 100mg may cause side effects. Commonly reported effects of olaparib include:

Nausea and vomiting

Fatigue or weakness

Reduced appetite

Diarrhoea or indigestion

Headache and dizziness

Anaemia and other changes in blood cell counts

More serious risks can include bone marrow suppression, severe blood abnormalities and, rarely, myelodysplastic syndrome or acute myeloid leukaemia. Lung inflammation has also been reported.

Patients should contact their oncology team promptly if they develop fever, unusual bruising or bleeding, persistent breathlessness, severe weakness or signs of infection. Emergency medical assessment may be necessary for severe symptoms.

Doctors may arrange regular blood tests and adjust or interrupt treatment when clinically appropriate.

Precautions and Safe Use

Bracanat 100mg must be taken only under the supervision of a qualified oncologist. The prescribed dose and duration depend on the indication, kidney function, other medicines and individual treatment response.

Tell your doctor about all medicines and supplements you use, as some can interact with olaparib. Pregnancy and breastfeeding require specific medical advice because of potential risks. Do not change the dose, crush tablets or stop treatment without consulting your healthcare professional.

Frequently Asked Questions (FAQs)

1. What is Bracanat 100mg used for?

It contains olaparib, a targeted anticancer medicine prescribed for selected cancers based on approved indications and relevant clinical or genetic factors.

2. Is Bracanat 100mg a chemotherapy medicine?

It is a targeted anticancer treatment called a PARP inhibitor. Although its mechanism differs from conventional chemotherapy, it can still cause significant adverse effects.

3. Can Bracanat 100mg be taken without a prescription?

No. Olaparib requires specialist medical supervision and must be used according to applicable prescription requirements.

4. Is Bracanat 100mg available in Singapore?

Availability and registration should be verified through Singapore's Health Sciences Authority (HSA) therapeutic product register before purchasing or supplying the medicine.

5. Where can healthcare professionals obtain product information?

Consult the current official prescribing information, approved product documentation and relevant local regulatory requirements.

About Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd can use this page to provide educational product information for healthcare professionals and other appropriate audiences, subject to applicable Singapore regulations. Product supply, registration, manufacturer details and distribution arrangements should be confirmed before publication.

Medical disclaimer: This page is for educational purposes only and does not replace professional medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before using anticancer medicines.